-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GK8dxxLvUdOvLTJDrX6sXMaBVyJo8doraUWvxCq7Hw/Z0Df4Gxrc04DJQzFRHogb 6043MZB13RkWiTqgX58M8Q== 0000000000-09-055013.txt : 20091113 0000000000-09-055013.hdr.sgml : 20091113 20090930121843 ACCESSION NUMBER: 0000000000-09-055013 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090930 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 PUBLIC REFERENCE ACCESSION NUMBER: 0001047469-09-002008 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@,3`V M.3(O3R`X+T4@-C4P."].(#$O5"`Q,#4R-B]((%L@-3DV(#$V.%T^/@UE;F1O M8FH-("`@("`@("`@("`@("`@("`@("`@#0IX%LP(#`@-C$R(#%LP(#`@-C$R(#'1=+T5X=$=3=&%T93P\+T=3 M,2`Q.2`P(%(^/CX^#65N9&]B:@TQ,"`P(&]B:@T\/"]3=6)T>7!E+U1R=654 M>7!E+T9O;G1$97-C7!E+T9O;G0^/@UE;F1O8FH- M,3(@,"!O8FH-6R])0T-"87-E9"`Q-2`P(%)=#65N9&]B:@TQ,R`P(&]B:@T\ M/"],96YG=&@@-S4Q+T9I;'1EY@13+81KD1")DVDS83W'0ZF1Y<(\`MV!G9"9/^^JX^;!-" M.[T4!KR2I;=OWS[I[&K!85U[%ZEWEJ8A<$A7'@^!X1(&6=P,A'O$G&;"/[S9R$?&[GS$RK(=ZD@%`,(&1.G^)\D/.P(#UV1 MZB=<49A76]DTV>'2L%V*+36U+6195`KNBUS"K9)UL91E,X!Y469E;@6=(K.0 MS'U.1^131TIC=$IQI]1$MT*0EVU1PNTF4W:8Y?*I*?)L6_L1'9(!(G$"[\N< M'J(=ZT[$,,:BJWTI88JDE(29*IYE6T[0U>,"W++(2I@5&%L*`<'R'TYZ$\_").(D;D^ M`A\K"BS@(F',TCD\@'K[Z.3AT_RBCFED@6>:T8W23L+.1<38Z?R/OCPJO.^G M,&N^2-ADV+^\VCTB$I99/2E0\KF0>ZA6\**'&H='5"`,>ZN@,ZV6T!\3K:(? MQ'1,KHU1#7I9P>I)H:Q*)]++T#NUY1SPL4$^I,F[>X6[>R5KL"O8T804-31X MNP@L7?KX1_]V)$.:&`'[^V+A8ULXGIT"@U&"/$O?-"K7XS&.91LH$YAQ-,3Q MMMWQ8G<,[,/F=WWL??`/5^E;=E<:,D1V3Q:[UBD%CL&.[\Q[4MG1TCXUX9BWDL?"; M@TV,3.TF-]DEZ+JQ,H$KYC+U?@LP`(?QH)$*#0IE;F1S=')E86T-96YD;V)J M#3$T(#`@;V)J#3P\+U-U8G1Y<&4O5')U951Y<&4O1F]N=$1E7!E M+T9O;G0^/@UE;F1O8FH-,34@,"!O8FH-/#PO3&5N9W1H(#(U.3@O1FEL=&5R M+T9L871E1&5C;V1E+TX@,R]!;'1E(>'N& MD"-BQ$?$!1E<3J:(;XM8,TF8S!7Q6W%L,H>9#@"*)+8+.*QX$9N(F,0/#G01 M\7(`<*2X+SCF"Q9PL@3B0[FDI&;SN7'Q`KHN2X]N:FW-H'MR,I,X`H&A/Y.5 MR.2SZ2XIR:E,7C8`BV?^+!EQ;>FB(EN:6EM:&IH9F7Y1J/^Z^#'[:_\4NH`8,R*:K/K#UO,?@`ZM@(@=_\/F^8A`"1%?6N_\<5Y:.)Y MB1<(4FV,C3,S,XVX'):1N*"_ZW\Z_`U]\3TC\7:_EX?NRHEE"I,$=''=6"E) M*4(^/3V5R>+0#?\\Q/\X\*_S6!K(B>7P.3Q11*AHRKB\.%&[>6RN@)O"HW-Y M_ZF)_S#L3UJ<:Y$H]9\`-5#<]=_[YH,/!>*;%Z8Z ML3CWGP7]^ZYPB?B1SHW['.<2&$QG"?D9BVOB:PG0@``D`17(`Q6@`72!(3`# M5L`6.`(WL`+X@6`0#M8"%H@'R8`/,D$NV`P*0!'8!?:"2E`#ZD$C:`$G0`0A54@+,H#,(`9D#[E!/E`@ M%`Y%0W$0#Q)"N=`6J`@JA2JA6J@1^A8Z!5V`KD(#T#UH%)J"?H7>PPA,@JFP M,JP-&\,,V`GVAH/A-7`WP!?@Z?`<>@9_#LPA`B`@- M44,,$0;B@O@A$4@LPDVH'M0MU"AJ!O4)348KH0W0-F@O]"IT'#H378`N1S>@ MV]"7T'?0X^@W&`R&AM'!6&$\,>&8!,PZ3#'F`*85P@=AS[%D?$J>+,<.ZX"!P/EX;P4 M7@MO@_?#L_'9^!)\/;X+?P,_CI\G2!-T"':$8$("83.A@M!"N$1X2'A%)!+5 MB=;$`"*7N(E803Q.O$(<);XCR9#T22ZD2)*0M)-TA'2>=(_TBDPF:Y,=R1%D M`7DGN9%\D?R8_%:"(F$DX27!EM@H4271+C$H\4(2+ZDEZ22Y5C)'LESRI.0- MR6DIO)2VE(L44VJ#5)74*:EAJ5EIBK2IM)]TLG2Q=)/T5>E)&:R,MHR;#%LF M7^:PS$69,0I"T:"X4%B4+91ZRB7*.!5#U:%Z41.H1=1OJ/W4&5D9V66RH;)9 MLE6R9V1':`A-F^9%2Z*5T$[0AFCOER@O<5K"6;)C2" ME?25`I76*1U6ZE.:5591]E!.5=ZO?%%Y6H6FXJB2H%*F>JOZ(PV"!D,C5J-, MHUMC1E-5TUYMVA_:DCIR.ETZ.3K/. M0UVRKH-NFFZ=[FT]C!Y#+U'O@-Y-?5C?0C]>OTK_A@%L8&G`-3A@,+`4O=1Z M*6]IW=)A0Y*ADV&&8;/AJ!'-R,OWS,3MV.:5=K-V)/MX^V/V0_XJ#FP'2H_M7]'B3O(.\*[V?^.C[\'VZ M?&'?%;Y[?!^NU%K)6]GA!_R\_/;X/?+7\4_S_SX`$^`?4!7P--`T,#>P-X@2 M%!74%/0FV#FX)/A!B&Z(,*0[5#(T,K0Q="[,-:PT;&25\:KUJZZ'*X1SPSLC ML!&A$0T1LZO=5N]=/1YI$5D0.;1&9TW6FJMK%=8FK3T3)1G%C#H9C8X.BVZ* M_L#T8]8Q9V.\8JIC9E@NK'VLYVQ'=AE[BF/'*>5,Q-K%EL9.QMG%[8F;BG>( M+X^?YKIP*[DO$SP3:A+F$OT2CR0N)(4EM2;CDJ.33_%D>(F\GA25E*R4@52# MU(+4D32;M+UI,WQO?D,ZE+XFO5-`%?U,]0EUA5N%HQGV&549;S-#,T]F26?Q MLOJR];-W9$_DN.=\O0ZUCK6N.U[TE;$M7OG+^IORQK1Y;FPLD"O@%P]MLM]5L1VWG;N_? M8;YC_XY/A>S":T4F1>5%'XI9Q=>^,OVJXJN%G;$[^TLL2P[NPNSB[1K:[;#[ M:*ET:4[IV![?/>UE]++"LM=[H_9>+5]67K./L$^X;Z3"IZ)SO^;^7?L_5,97 MWJERKFJM5JK>43UW@'U@\*#CP98:Y9JBFO>'N(?NUGK4MM=IUY4?QAS../RT M/K2^]VO&UXT-"@U%#1^/\(Z,'`T\VM-HU=C8I-14T@PW"YNGCD4>N_F-ZS>= M+88MM:VTUJ+CX+CP^+-OH[\=.N%]HOLDXV3+=UK?5;=1V@K;H?;L]IF.^(Z1 MSO#.@5,K3G5WV7:U?6_T_9'3:J>KSLB>*3E+.)M_=N%R_O9]R??[#I(?IAX2.I1^6/E1[7_:CW8^N(Y_Y3^TX?Q_*?DI^43JA.-DV:3IZ?]9_]O&;Y#?S?<=X MU_L^[/W$?.8'[(>*CWH?NSYY?WJXD+RP\)L``P#WA//["@T*96YD%LM-30W("TS,#<@,3(P-B`Q,#,R72]!7!E+T9O;G1$97-C2A4 M:6UE7!E+T5X=$=3=&%T M92]302!F86QS92]332`P+C`R/CX-96YD;V)J#3$@,"!O8FH-/#PO3G5MFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&%P+S$N,"\B/@H@("`@("`@("`\>&%P.D-R96%T;W)4;V]L M/E!38W)I<'0U+F1L;"!697)S:6]N(#4N,BXR/"]X87`Z0W)E871O&UL;G,Z9&,](FAT='`Z M+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M M($%M>6QI;DY&0RYD;V,\+W)D9CIL:3X*("`@("`@("`@("`@/"]R9&8Z06QT M/@H@("`@("`@("`\+V1C.G1I=&QE/@H@("`@("`@("`\9&,Z8W)E871O&%P34TZ26YS=&%N8V5)1#YU=6ED.F(P8C`Q M9&-E+3$Y9#4M-&(S.2UA9C`T+3DY-CDX,F0P-&5E83PO>&%P34TZ26YS=&%N M8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#PO6QI;DY&0RYD;V,I/CX-96YD;V)J#7AR968-"C`@-@T*,#`P M,#`P,#`P,"`V-34S-2!F#0HP,#`P,#`V-3`X(#`P,#`P(&X-"C`P,#`P,#8U M-#(@,#`P,#`@;@T*,#`P,#`P-C4V-B`P,#`P,"!N#0HP,#`P,#`V-C$W(#`P M,#`P(&X-"C`P,#`P,3`R.#D@,#`P,#`@;@T*=')A:6QE<@T*/#PO4VEZ92`V ;/CX-"G-T87)T>')E9@T*,3$V#0HE)45/1@T* ` end -----END PRIVACY-ENHANCED MESSAGE-----